310 related articles for article (PubMed ID: 32785606)
1. LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis.
Tian S; Liu J; Kong S; Peng L
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32785606
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
[TBL] [Abstract][Full Text] [Related]
3. The clinicopathological and prognostic value of long non-coding RNA ZEB1-AS1 in solid tumors: A meta-analysis.
Liang C; Liu J; Ge H; Xu Y; Li G; Wu J
Clin Chim Acta; 2018 Sep; 484():91-98. PubMed ID: 29778540
[TBL] [Abstract][Full Text] [Related]
4. LncRNA ZEB1-AS1 expression in cancer prognosis: Review and meta-analysis.
Chen C; Feng Y; Wang X
Clin Chim Acta; 2018 Sep; 484():265-271. PubMed ID: 29885321
[TBL] [Abstract][Full Text] [Related]
5. The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles.
Zhang Y; Liang C; Zhang Y; Wang Z; Li R; Wei Z; Guo J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140822
[TBL] [Abstract][Full Text] [Related]
6. LncRNA NR2F1-AS1 as a potential biomarker for prognosis in cancer patients: meta and bioinformatics analysis.
Tang L; Liu QM; Zhang S; Zhou J
Expert Rev Mol Diagn; 2023; 23(12):1263-1272. PubMed ID: 37902251
[TBL] [Abstract][Full Text] [Related]
7. LncRNA LOXL1-AS1 expression in cancer prognosis: A meta-analysis.
Wang X; Chen Z; Zhou H; Liu W; Luo J
Medicine (Baltimore); 2022 Dec; 101(52):e32436. PubMed ID: 36596047
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
[TBL] [Abstract][Full Text] [Related]
9. The clinical prognostic value of long noncoding RNA HAND2-AS1 in cancer patients: A study based on meta-analysis and TCGA data (PRISMA).
Yan Z; Lu J; Xu X; You Y; Xu J; Xu T
Medicine (Baltimore); 2022 Sep; 101(39):e30789. PubMed ID: 36181101
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and clinicopathological significance of long noncoding RNA H19 overexpression in human solid tumors: evidence from a meta-analysis.
Liu FT; Pan H; Xia GF; Qiu C; Zhu ZM
Oncotarget; 2016 Dec; 7(50):83177-83186. PubMed ID: 27825121
[TBL] [Abstract][Full Text] [Related]
12. DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA.
Hu C; Liu K; Wang B; Xu W; Lin Y; Yuan C
Curr Pharm Des; 2021; 27(9):1211-1218. PubMed ID: 33121401
[TBL] [Abstract][Full Text] [Related]
13. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
[TBL] [Abstract][Full Text] [Related]
14. Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers.
Zhang C; Ren X; Liu Z; Tu C
BMC Cancer; 2020 Sep; 20(1):879. PubMed ID: 32928135
[TBL] [Abstract][Full Text] [Related]
15. Expression of lncRNA DLX6-AS1 in patients with hepatic carcinoma and its prognostic value.
Lin Y; Zhang B; Su L; Wei J; Chen Z; Wu M
Biotechnol Genet Eng Rev; 2023 Apr; ():1-12. PubMed ID: 37078565
[TBL] [Abstract][Full Text] [Related]
16. The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis.
Wang J; Zhong P; Hua H
Technol Cancer Res Treat; 2021; 20():15330338211004915. PubMed ID: 33906548
[TBL] [Abstract][Full Text] [Related]
17. Clinical Value of Long Noncoding RNA HOTAIR as a Novel Biomarker in Digestive Cancers: A Meta-Analysis.
Zhang Y; Zhou Y; Xu T; Tian W; Yang C; Wang X; Zhong S; Ran Q; Yang H; Zhu S
Technol Cancer Res Treat; 2018 Jan; 17():1533034618756783. PubMed ID: 29444619
[TBL] [Abstract][Full Text] [Related]
18. The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets.
Shu Q; Liu X; Yang J; Mou T; Xie F
Medicine (Baltimore); 2022 Oct; 101(42):e31439. PubMed ID: 36281152
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis.
Zhong P; Hua H; Chen S; Zhu Z; Xie F
Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192
[TBL] [Abstract][Full Text] [Related]
20. Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer.
Ding XZ; Zhang SQ; Deng XL; Qiang JH
Technol Cancer Res Treat; 2021; 20():1533033821990060. PubMed ID: 33550924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
